Abstract:There is no effective treatment for rabies, and its preventive measures are mainly vaccinated against human rabies before or after exposure. With the development of rabies vaccine production technology, the quality of vaccines has been continuously improved, and its immunization procedures have been continuously improved. At present, intramuscular injection is commonly used for rabies vaccination in China. The pre-exposure immunization program is one injection of the vaccine on day 0, 7, 21, or 28; the post-exposure immunization program is 5 The acupuncture method and the 2-1-1 method, and the re-exposure immunization program are inoculated with different doses of the vaccine according to the interval between immunizations after the first exposure. The 2018 Rabies Vaccine: WHO Position Paper simplifies rabies exposure prevention and immunization procedures based on recent advances in rabies research. Based on the new position paper, this article summarizes the research progress of rabies exposure prevention and treatment procedures at home and abroad, and discusses the differences between China's rabies vaccine immunization program and the immunization program advocated by the new position paper and the improvement plans.
宋云, 于鹏程, 朱武洋. 人用狂犬病疫苗肌肉注射免疫程序研究进展[J]. 中国人兽共患病学报, 2020, 36(2): 158-162.
SONG Yun, YU Peng-cheng, ZHU Wu-yang. Advance in reseach on intramuscular immunization program for human rabies vaccine. Chinese Journal of Zoonoses, 2020, 36(2): 158-162.
[1] Lafon M. Rabies virus receptors[J].J Neurovirol,2005,11(1):82-87. DOI: 10.1080/13550280590900427 [2] Taylor LH, Hampson K, Fahrion A, et al. Difficulties in estimating the human burden of canine rabies [J].Acta Trop,2017,165:133-140. DOI: 10.1016/j.actatropica.2015.12.007 [3] World Health Organization. Rabies vaccines: WHO position paper, April 2018-Recommendations[J].Vaccine,2018,36(37):5500-5503. DOI: 10.1016/j.vaccine.2018.06.061 [4] Roumiantzeff M, Ajjan N, Vincent-Falquet JC. Experience with preexposure rabies vaccination[J].Rev Infect Dis,1988,10 Suppl 4:S751-S757. DOI: 10.1093/clinids/10.supplement_4.s751 [5] Strady A, Lang J, Lienard M, et al. Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy[J]. J Infect Dis,1998,177(5):1290-1295. DOI: 10.1086/515267 [6] Pengsaa K, Limkittikul K, Sabchareon A, et al. A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine[J].Pediatr Infect Dis J,2009,28(4):335-337. DOI: 10.1097/INF.0b013e3181906351 [7] WHO Publication. Rabies vaccines: WHO position paper-recommendations[J].Vaccine,2010,28(44):7140-7142. DOI: 10.1016/j.vaccine.2010.08.082 [8] Manning SE, Rupprecht CE, Fishbein D, et al. Human rabies prevention-United States, 2008: recommendations of the Advisory Committee on Immunization Practices[J].MMWR Recomm Rep,2008,57(RR-3):1-28. DOI:10.1111/j.1600-6143.2011.03793.x [9] Warrell MJ. Developments in human rabies prophylaxis. Developments in human rabies prophylaxis[J].Rev Sci Tech,2018,37(2):629-647. DOI: 10.20506/rst.37.2.2829 [10] Sehgal S, Bhattacharya D, Bhardwaj M. Ten year longitudinal study of efficacy and safety of purified chick embryo cell vaccine for pre- and post-exposure prophylaxis of rabies in Indian population[J].J Commun Dis,1995,27(1):36-43. [11] Khawplod P, Jaijaroensup W, Sawangvaree A, et al. One clinic visit for pre-exposure rabies vaccination (a preliminary one year study) [J].Vaccine,2012,30(19):2918-2920. DOI: 10.1016/j.vaccine.2011.12.028 [12] 王军. 狂犬病暴露预防处置工作规范(2009年版)[J]. 中国工作犬业,2010,(02):62-63. DOI:CNKI:SUN:GZQY.0.2010-02-041 [13] 狂犬病预防控制技术指南(2016版)[J]. 中华流行病学杂志,2016,(37):163. DOI:10.3760/cma.j.issn.0254-6450.2016.02.001 [14] Morris J, Crowcroft NS, Fooks AR, et al.Rabies antibody levels in bat handlers in the United Kingdom: immune response before and after purified chick embryo cell rabies booster vaccination[J].Hum Vaccin,2007,3(5):165-170. DOI: 10.4161/hv.3.5.4216 [15] 陈恩富, 王臻, 胡建锦, 等.国产纯化 Vero 细胞狂犬病疫苗暴露前免疫效果观察[J].中华流行病学杂志,2009,30(1):33. DOI:10.3760/cma.j.issn.0254-6450.2009.01.009 [16] Soentjens P, Andries P, Aerssens A, et al. Preexposure intradermal rabies vaccination: a noninferiority trial in healthy adults on shortening the vaccination schedule from 28 to 7 days[J].Clin Infect Dis,2019,68(4):607-614. DOI: 10.1093/cid/ciy513 [17] Manickama R, Basheer MD, Jayakumar R. Post-exposure prophylaxis (PEP) of rabies-infected Indian street dogs[J].Vaccine,2008,26(51):6564-6568. DOI: 10.1016/j.vaccine.2008.09.053 [18] Peck F B, Powell H M, Culbertson C G. Duck-embryo rabies vaccine; study of fixed virus vaccine grown in embryonated duck eggs and killed with beta-propiolactone (BPL) [J]. J Am Med Assoc,1956,162(15):1373-1376. [19] Centers for Disease Control and Prevention. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies-recommendations of the Advisory Committee on Immunization Practice[J].Ann Emerg Med,2010,56(1):64-67. DOI: 10.1016/j.annemergmed.2010.05.020 [20] Vodopija I, Sureau P, Smerdel S, et al. Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment[J]. Vaccine,1988,6(3):283-286. DOI: 10.1016/0264-410x(88)90225-3 [21] Mittal MK. Revised 4-dose vaccine schedule as part of postexposure prophylaxis to prevent human rabies[J].Pediatr Emerg Care,2013,29(10):1119-1124. DOI: 10.1097/PEC.0b013e3182a63125 [22] WHO Publication. Rabies vaccines: WHO position paper-recommendations[J].Vaccine,2010,28(44):7140-7142. DOI: 10.1016/j.vaccine.2010.08.082 [23] 卫生部. 狂犬病暴露后处置工作规范(试行)[J]. 中国护理管理, 2006, 6(11):6-6. [24] Duin VD. Vaccines, 6th Edition[J]. Clinical Infectious Diseases, 2013, 56(12):1848-1849. DOI:10.1093/cid/cit141 [25] 叶茂华, 雷永良, 王晓光. 7 例被狂犬咬伤者接种狂犬病疫苗的效果观察[J]. 中国生物制品学杂志,2008,21(12):1046-1046. DOI:10.3969/j.issn.1004-5503.2008.12.025 [26] Hu Q, Liu MQ, Zhu ZG, et al. Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China[J].Hum Vaccin Immunother,2014,10(6):1645-1649. DOI: 10.4161/hv.28420 [27] Rupprecht CE, Briggs D, Brown CM, et al. Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals[J].Vaccine, 2009,27(51):7141-7148. DOI: 10.1016/j.vaccine.2009.09.029 [28] Wang LY, Sun MP, Zhang XC, et al. Safety and immunogenicity of two freeze-dried vero cell rabies vaccines for human use in post-exposure prophylaxis[J].Vaccine,2011,29(15):2679-2681. DOI: 10.1016/j.vaccine.2011.01.053 [29] Chutivongse S, Wilde H, Fishbein DB, et al. One-year study of the 2-1-1 intramuscular postexposure rabies vaccine regimen in 100 severely exposed Thai patients using rabies immune globulin and Vero cell rabies vaccine[J].Vaccine,1991,9(8):573-576. DOI: 10.1016/0264-410x(91)90244-z [30] 陈直平, 吕华坤, 王慎玉, 等. Zagreb方案接种国产人二倍体细胞狂犬病疫苗的免疫原性观察[J]. 中国急救复苏与灾害医学杂志,2018,(11):1069-1071. [31] Aoki FY, Rubin ME, Friesen AD, et al. Intravenous human rabies immunoglobulin for post-exposure prophylaxis: serum rabies neutralizing antibody concentrations and side-effects[J].J Biol Stand,1989,17(1):91-104. DOI: 10.1016/0092-1157(89)90032-2 [32] Wasi C, Chaiprasithikul P, Auewarakul P, et al. The abbreviated 2-1-1 schedule of purified chick embryo cell rabies vaccination for rabies postexposure treatment[J].Southeast Asian J Trop Med Public Health,1993,24(3):461-466. [33] Kuwert EK, Werner J, Marcus I, et al. Immunization against rabies with rabies immune globulin, human (RIGH) and a human diploid cell strain (HDCS) rabies vaccine[J].J Biol Stand,1978,6(3):211-219. DOI: 10.1016/s0092-1157(78)80007-9 [34] Lowenstein W. Comparison of primary and delayed wound closure of dog-bite wounds[J].Vet Comp Orthop Traumatol,2013,26(3):204-207. DOI: 10.3415/VCOT-12-04-0053 [35] Mclean HQ, Organization WH. The immunological basis for immunization series: module 17: rabies[J]. Geneva World Health Organization, 2011. [36] World Health Organization. WHO Expert Consultation on Rabies. Second report[R]. World Health Organ Tech Rep Ser,2013,(982).